THE VALUE OF BONE-SCINTIGRAPHY IN THE FOLLOW-UP OF VERTEBRAL OSTEOPOROSIS

被引：5

作者：

RICO, H

MERONO, E

DELOLMO, J

REVILLA, M

机构：

[1] Departamento de Medicina, Universidad de Alcala de Henares, Madrid

[2] Nuclear Medicine Service, San Carlos University Hospital, Madrid

来源：

CLINICAL RHEUMATOLOGY | 1991年 / 10卷 / 03期

关键词：

SCINTIGRAPHIC INDEX; VERTEBRAL OSTEOPOROSIS; CALCITONIN;

D O I：

10.1007/BF02208694

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In an open study, we have assessed the bone/soft tissue uptake index in recent osteoporotic vertebral collapse using scintigraphy. The evolution of these cases was followed-up at 6 months in 22 patients treated with 100 IU of salmon calcitonin plus 500 mg of elemental calcium/10 days per month and in 18 patients treated with 500 mg of elemental calcium only on a daily basis. There were no index differences between groups prior to treatment. At six months, the group treated with calcitonin plus calcium showed a significant decrease from 10.2 +/- 6.4 to 3.2 +/- 1.1 (p < 0.001), while the calcium only group did not show any significant changes (12.1 +/- 6.6 vs 9.2 +/- 4.6), considering that there were significant differences between groups (p < 0.001). On a mid-term basis, these results have shown the values of the bone/soft tissue index in the follow-up of osteoporotic vertebral collapse.

引用

页码：298 / 301

页数：4

共 24 条

[1]

Fogelman I., Bone scanning and photon absorptiometry in metabolic bone disease, Bailliere's Clin Endocrinol Metab, 2, pp. 59-86, (1988)

[2]

Alazraki N., Radionuclide techniques, Diagnosis of bone and joint disorders, pp. 460-505, (1988)

[3]

Mazess R.B., Wahner H.M., Nuclear medicine and densitometry, Osteoporosis: etiology, diagnosis and management, pp. 251-295, (1988)

[4]

Rosenthall L., Kaye M., Technetium-99m-pyrophosphate Kinetics and imaging bone disease, J Nucl Med, 16, pp. 33-39, (1975)

[5]

Wahner H.W., Assessment of metabolic bone disease: review of new nuclear medicine procedures, Mayo Clin Proc, 60, pp. 827-835, (1985)

[6]

Fogelman I., Citrin D.L., Tuner J.G., Hay I.D., Bessent R.G., Boyle I.T., Semi-quantitative interpretation of the bone scan in metabolic bone disease: definition and validation of the metabolic index, Eur J Nucl Med, 4, pp. 287-289, (1979)

[7]

Rico H., Merono E., Gomez-Castresana F., Torrubiano J., Espinos D., Diaz P., Scintigraphy evaluation of reflex sympathetic dystrophy: comparative study of the curse of the disease under two therapeutic regimens, Clin Rheumatol, 6, pp. 73-77, (1987)

[8]

Resnick D., Niwayama G., Osteoporosis, Diagnosis of bone and joint disorders, pp. 2022-2085, (1988)

[9]

Albanese A.A., Edelson A.H., Woodhull M.W., Lorenze E.J., Wein E.H., Orto L.A., Effect of a calcium supplement on serum cholesterol, calcium, phosphorus and bone density of “normal healthy” elderly females, Nutr Rep Int, 8, pp. 119-130, (1973)

[10]

Raisz L.G., Smith J., Osteoporosis, Clinical endocrinology of calcium metabolism, pp. 201-249, (1987)

← 1 2 3 →